iBio Inc
IBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$56.01M
Close$
$0.52
34% downside
Current Fair Value
34% downsideOvervalued by 34% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $56.01 Million |
|---|---|
| Enterprise Value | $1.81 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.32 |
| Beta | 1.26 |
| Outstanding Shares | 104,060,000 |
Return
| Return on Equity | -38.55% |
|---|---|
| Return on Assets | -33.34% |
| Return on Invested Capital | -13.22% |
Valuation & Multiples
| P/E Ratio | -2.68 |
|---|---|
| PEG | -2.54 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 18.15 |
| Enterprise Value to EBIT | -0.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.21 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 29, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$80,000
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$25,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 33.38%▲ 17.14% |
|---|---|
| Total Invested | $60.80M▲ 64.71% |
| Investors Holding | 56▲ 4.00% |
ESG Score
No data